ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1358

Relationship between Serum Protein Pattern and High Disease Activity in Patients with Rheumatoid Arthritis

Pavel Horak1, Anna Petráčková2, Martina Skácelová3, Eva Kriegová4, Petra Schneiderová5 and František Mrázek5, 1III. Department of internal medicine, III. Department of Internal Medicine, Faculty of Medicine and Dentistry, Palacký University of Olomouc, Olomouc, Czech Republic, 2Department of Immunology, Department of Immunology, Faculty of Medicine and Dentistry, Palacky University of Olomouc, Olomouc, Czech Republic, 3III. Department of Internal Medicine, Faculty of Medicine and Dentistry, Palacký University of Olomouc, Olomouc, Czech Republic, 4Department of Immunology,, Faculty of Medicine and Dentistry, Palacky University of Olomouc, Olomouc, Czech Republic, 5Department of Immunology, Faculty of Medicine and Dentistry, Palacky University of Olomouc, Olomouc, Czech Republic

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Disease Activity, proteomics and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 6, 2017

Title: Rheumatoid Arthritis – Clinical Aspects Poster II: Pathophysiology, Autoantibodies, and Disease Activity Measures

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Rheumatoid arthritis (RA) is a chronic autoimmune disease that primarily affects joints. There is still limited information of serum biomarkers suitable for effective monitoring of disease activity. To assess RA-associated serum protein signature using highly sensitive multiplex Proximity Extension ImmunoAssay (PEA) and its relationship with disease activity evaluated by activity score (DAS28).

Methods: We investigated the serum levels of 92 inflammation-related proteins in 78 Czech patients with RA and 38 age-matched healthy control (C) subjects using a highly sensitive innovative multiplex PEA (Proseek Multiplex, Olink Bioscience, Sweden). Statistical tests (Mann-Whitney U test, Benjamini-Hochberg correction, Spearman correlation) were performed using GenEx (Sweden), P-value ≤ 0.05 was considered as significant.

Results:

Top-ranked proteins distinguishing RA and C (Pcorr<0.0001) were sTNFSF14, sulfotransferase 1A1, IL-6, axin 1, CCL7, caspase 8, oncostatin M, sirtuin 2, sTGFα, CCL3, sHGF, sCD40, STAMBP, FGF23, CXCL10, and sSLAMF1. Of them, upregulation of sulfotransferase 1A1, axin 1, and GDNF was not reported in RA yet. Disease activity positively correlated with CCL20 (r=0.495, P=0.000004), CCL7 (r=0.442, P=0.00005), CXCL1, CXCL9, IL-6, sCDCP1, GDNF, CXCL10 (r>0.30, P<0.006), and negatively correlated with IL-12B and sCD244 (r<-0.304, P<0.007). Subanalysis of protein pattern in patient phenotypes is ongoing.

Conclusion: Among the entire panel, the chemokines CCL20, CCL7, CXCL1, CXCL9, CXCL10 and GDNF appeared to be the most useful serum markers for evaluation of the disease activity of patients with RA. Further multivariate analysis is needed to identify pattern associated with high disease activity.

Acknowledgement: Grant support: MZ CR VES15-28659A, IGA_LF_2017_009



Disclosure: P. Horak, None; A. Petráčková, None; M. Skácelová, None; E. Kriegová, None; P. Schneiderová, None; F. Mrázek, None.

To cite this abstract in AMA style:

Horak P, Petráčková A, Skácelová M, Kriegová E, Schneiderová P, Mrázek F. Relationship between Serum Protein Pattern and High Disease Activity in Patients with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/relationship-between-serum-protein-pattern-and-high-disease-activity-in-patients-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/relationship-between-serum-protein-pattern-and-high-disease-activity-in-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology